Harmony Biosciences Holdings, Inc. Total Debt 2019–2025
Harmony Biosciences Holdings, Inc. reported $163.66M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 8.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -15.7%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $163.66M | -8.7% |
| FY 2024 | $179.27M | -7.4% |
| FY 2023 | $193.57M | +1.0% |
| FY 2022 | $191.65M | -0.2% |
| FY 2021 | $191.98M | -1.2% |
| FY 2020 | $194.25M | +98.3% |
| FY 2019 | $97.95M | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HRMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Harmony Biosciences Holdings, Inc. reported $163.66M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 8.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -15.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s total debt (short- plus long-term borrowings)?
Harmony Biosciences Holdings, Inc. (HRMY) reported total debt (short- plus long-term borrowings) of $163.66M for fiscal year 2025, per its SEC filings.
How has Harmony Biosciences Holdings, Inc.'s total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2019 and 2025, HRMY's total debt (short- plus long-term borrowings) grew at roughly 8.9% per year (compound annual rate), from $97.95M to $163.66M.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More HRMY financial history
Full HRMY fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →